Zelrix, A Migraine Patch, Is Moving Forward

Pharmaceutical company NuPathe Inc. out of Conshohocken, PA has just announced positive results from Phase III clinical trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraines.

Zelrix relies on the company's proprietary iontophoretic transdermal technology, called SmartRelief™, to continuously deliver sumatriptan. The big idea behind Zelrix, "a thin, disposable, single-use device in a self-contained system," is to give migraine sufferers a new therapeutic option with a proven medication, so they can stick on a patch and get medication fast and consistently, regardless of nausea, vomiting, or other gastric symptoms associated with migraine.

Via: medgadget.com